Macular Degeneration Treatment Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2028

1
Global Macular Degeneration Treatment Market
Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Macular Degeneration Treatment Market
Research Report The latest report by IMARC,
titled Macular Degeneration Treatment Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028 finds that
the global macular degeneration treatment market
size reached US 8.9 Billion in 2022. Macular
degeneration is a neurodegenerative eye disorder
caused by deterioration of the macula, the part
of the retina that controls sharp, straight-ahead
vision. It leads to blurred or complete vision
loss in the center of the visual field. The
condition is generally characterized by blind or
blurry spots in the field of vision, visual
distortions, and the inability to see in low
light conditions. It can be treated by various
therapeutic techniques, such as anti-angiogenic
drugs, photodynamic laser therapies, contact
lenses, and transitional lenses. In recent years,
macular degeneration treatment has gained immense
traction across the globe as timely treatment can
help improve vision and reduce the risks of
developing chronic or permanent
blindness. Request Free Sample Report
https//www.imarcgroup.com/macular-degeneration-tr
eatment-market/requestsample
4
Report Description and Highlights
Report Description

Global Macular Degeneration Treatment Market
Trends The rising incidences of retinal
disorders and the surging awareness regarding
available treatment options among the masses
represent the primary factors driving the market
growth. Besides this, since macular degeneration
usually affects older adults, the expanding
geriatric population is another major
growth-inducing factor. Additionally, there has
been a widespread prevalence of obesity and
cardiovascular diseases (CVDs) due to sedentary
lifestyles, changing dietary patterns, and
unhealthy habits like smoking. In line with this,
prolonged screen time owing to the growing usage
of smartphones, laptops, and television is
contributing to the development of eye
conditions, which has augmented the demand for
macular degeneration treatment. Furthermore,
the leading players are extensively investing in
research and development (RD) activities to
develop innovative and effective drugs. Along
with this, the introduction of retinal gene
therapies that involve injecting adeno-associated
virus (AAV) into the body to prevent the growth
of abnormal blood vessels has propelled the
market growth. Other factors, including the
rising popularity of biosimilars, increasing
approvals of novel drugs, favorable government
initiatives, improving healthcare infrastructure,
and technological advancements, are also
providing a positive thrust to the market growth.
Looking forward, IMARC Group expects the market
value to reach US 12.9 Billion by 2028, growing
at a CAGR of 6.2 during the forecast period
(2023-2028). Looking forward, the market value
is projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Type Dry A
ge-related Macular Degeneration
Wet Age-related Macular Degeneration
Breakup by Stage of Disease Early
Stage Intermediate Stage Late
Stage Breakup by Route of Administration
Intravenous Route Intravitreal Route
Breakup by End User Hospitals
Ambulatory Surgical Center Others

6
Report Description and Highlights
Report Description
Breakup by Region North America
United States Canada
Asia-Pacific China
Japan India
South Korea Austra
lia Indonesia
Others Europe Germany
France United
Kingdom Italy
Spain Russia

7
Report Description and Highlights
Report Description
Others Latin America
Brazil Mexico
Others Middle East and
Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Aerie Pharmaceuticals Inc
• Bausch Health Companies Inc. Bayer AG F. Hoffmann
  -La Roche Ltd Iveric Bio Inc. Novartis AG Panoptic
  a Pfizer Inc. Phio Pharmaceuticals Regeneron Pharm
  aceuticals Inc. Regenxbio Inc. Santen Pharmaceutic
  al Co. Ltd.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/macular-degeneration-tr
  eatment-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us